In this GEN webinar, DNA synthesis experts Michael Junkin, PhD, and Brittany Enzmann, PhD, will provide an exclusive first look at Elegen’s GEN II Cell-Free DNA production platform that combines ...

Liver cells exposed to a high fat diet revert to an immature state that is more susceptible to cancer-causing mutations.

A new study shows how histones undergo correct chemical modifications during synthesis to guide new therapies.

GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.

JAX and the NYSCF celebrated the official launch of their unified organization with a ribbon-tying ceremony at NYSCF’s Manhattan research facilities.

Researchers suggest that MultiCell could potentially be used to discern early patterns of disease, such as in asthma.

AI can move beyond prediction to purposeful molecular design, creating proteins that meet clearly defined research and therapeutic goals.

Vaccines that display filovirus surface proteins on engineered, self-assembling protein nanoparticles improve immune system detection of the virus.

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

Lyophilization model can help optimize freeze-drying steps for continuous manufacturing processes, according to MIT researchers.

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.